Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Central Nervous System Neoplasms 1Central Nervous System Diseases 1

Interventions

Psychiatric Rehabilitation 4Immunohistochemistry 4Gene Expression Profiling 4Amplified Fragment Length Polymorphism Analysis 4Radiotherapy 3gadobenic acid 2Surveys and Questionnaires 2Polymerase Chain Reaction 2Microarray Analysis 2Mental Status and Dementia Tests 2Magnetic Resonance Imaging 2In Situ Hybridization, Fluorescence 2Gene Rearrangement 2Cytogenetic Analysis 2Comparative Genomic Hybridization 2gadoteridol 1Vincristine 1Tissue Banks 1Temozolomide 1Specimen Handling 1Respiratory Function Tests 1Radiosurgery 1Quality of Life 1Pulse Wave Analysis 1Positron-Emission Tomography 1Phlebotomy 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Methotrexate 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Central Nervous System Neoplasms × gadoteridol × Clear all
NCT03750188 2020-01-23

Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrs

Bracco Diagnostics, Inc

Completed
125 enrolled
CNS

Central Nervous System Diseases, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡